EIKO Lifesciences Quarterly Results for Trading Insights
EIKO • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹1 Cr
QSept 2025
EIKO Lifesciences Quarterly Results Key Highlights
- Revenue of ₹12 Cr in Sept 2025 (+0.0% vs Mar 2025, +50.0% vs Sept 2024)
- Net Profit of ₹1 Cr in Sept 2025 (+0.0% vs Mar 2025)
- EBITDA of ₹2 Cr in Sept 2025 (+0.0% vs Mar 2025)
- Operating Margin of 15.0% in Sept 2025 (+3.0pp vs Mar 2025)
- Earnings Per Share of ₹0.78 in Sept 2025 (-2.5% vs Mar 2025)
EIKO Lifesciences Quarterly Results Analysis
| Metric | Sept 2025 | Mar 2025 | Jun 2025 | Sept 2024 | Jun 2024 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 12 | 12 | 11 | 8 | 11 | - | 50.0% |
| Net Profit (₹ Cr) | 1 | 1 | 1 | 0 | 0 | - | - |
| EBITDA (₹ Cr) | 2 | 2 | 2 | 1 | 1 | - | - |
| EPS (₹) | 0.78 | 0.80 | 0.66 | 0.22 | 0.29 | - | - |
| Operating Margin (%) | 15.0% | 12.0% | 14.0% | 5.0% | 4.0% | - | - |
EIKO Lifesciences Share Price Trend Around Quarterly Results
Visualize EIKO Lifesciences's 1-year price movement across quarterly results — ideal for logging trades in EIKO Lifesciences share price
chart using Tickjournal. All values in ₹.
Related Pages for EIKO Lifesciences
Additional stock information and data for EIKO
Revenue Trend (₹ Cr)
Sept 2024
8
Jun 2025
11
Mar 2025
12
Sept 2025
12
Net Profit Trend (₹ Cr)
Sept 2024
0
Jun 2025
1
Mar 2025
1
Sept 2025
1
Operating Margin Trend (%)
Sept 2024
5.0%
Jun 2025
14.0%
Mar 2025
12.0%
Sept 2025
15.0%
Sector Competitors - Quarterly Performance Comparison
Comparing EIKO Lifesciences quarterly results with other companies in Chemicals sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Pidilite Industries
Sept 2025 |
₹149,084.93 Cr | 1464.9 | 3,605 | 585 | +11.9% | - | 16.2% | 257.5 |
|
SRF
Sept 2025 |
₹83,989.01 Cr | 2689.1 | 3,560 | 388 | -16.2% | - | 10.9% | 205.3 |
|
Coromandel Internat…
Sept 2025 |
₹67,477.25 Cr | 2274.8 | 9,771 | 793 | +78.9% | - | 8.1% | 83.2 |
|
UPL
Sept 2025 |
₹61,081.58 Cr | 752.4 | 12,411 | 612 | -20.8% | - | 4.9% | 111.5 |
|
Linde
Sept 2025 |
₹58,846.11 Cr | 6794.0 | 650 | 171 | +7.4% | - | 26.3% | 338.9 |
Sector Quarterly Performance Comparison
Chemicals sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores